Summary & Overview
CPT 86357: Natural Killer (NK) Cell Count
CPT code 86357 represents a laboratory immunology test that measures the total count of natural killer (NK) cells in peripheral blood. The test provides objective data on a patient’s innate immune cell population and is used in clinical evaluation of immune status, monitoring of certain immunodeficiencies, and in select specialty care settings. Nationally, utilization of NK cell quantification is relevant to laboratory services, immunology practices, and hospital outpatient diagnostics.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for the test, common sites of service, and the payer landscape relevant to laboratory reimbursement. The publication outlines typical billing practice considerations, common modifier usage (listed separately), and where this code fits within immunology and hematology testing portfolios.
This summary prepares clinicians, laboratory managers, and billing professionals to understand what CPT code 86357 denotes, why it is used clinically, and which major payers typically process claims for NK cell counting. Data not available in the input is noted where applicable in detailed sections.
Billing Code Overview
CPT code 86357 describes a laboratory test that measures the total count of natural killer (NK) cells in a patient’s immune system, typically performed on a blood specimen. This test quantifies NK cells to inform clinical assessment of immune function.
Service type: Laboratory test — immunology/flow cytometry
Typical site of service: Clinical laboratory or hospital outpatient laboratory
Clinical & Coding Specifications
Clinical Context
A typical patient is a 42-year-old adult referred by an immunologist or infectious disease specialist for quantification of natural killer (NK) cells after recurrent viral infections, persistent warts, unexplained lymphopenia on complete blood count, or as part of immune evaluation in suspected primary immunodeficiency. The clinician orders the assay to measure total NK cell count from peripheral blood; a phlebotomy appointment is scheduled at an outpatient laboratory or hospital outpatient phlebotomy service. The specimen is collected in anticoagulated whole blood, labeled, and transported to the clinical flow cytometry laboratory. A laboratory technologist performs immunophenotyping using flow cytometry to identify CD16+/CD56+ cells (or equivalent markers) and reports an absolute NK cell count and percentage. Results are reviewed by the ordering clinician to guide diagnosis, immunologic workup, or therapy monitoring (for example, before or after immunomodulatory treatment). Typical sites of service include outpatient hospital laboratory, freestanding clinical laboratory, or tertiary hospital outpatient clinic.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when only the professional interpretation component is billed separately from the technical component. |
TC |